1146 related articles for article (PubMed ID: 10908538)
1. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
Ramaker C; Hilten JJ
Cochrane Database Syst Rev; 2002; (2):CD003634. PubMed ID: 12076493
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine versus levodopa in early Parkinson's disease.
van Hilten JJ; Ramaker CC; Stowe R; Ives NJ
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD002258. PubMed ID: 17943771
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
van Hilten JJ; Ramaker CC; Stowe R; Ives NJ
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003634. PubMed ID: 17943795
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
van Hilten JJ; Ramaker C; Van de Beek WJ; Finken MJ
Cochrane Database Syst Rev; 2000; 1998(2):CD001203. PubMed ID: 10796755
[TBL] [Abstract][Full Text] [Related]
6. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2000; 2001(3):CD001517. PubMed ID: 10908504
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
Ramaker C; van de Beek WJ; Finken MJ; van Hilten BJ
Mov Disord; 2000 Jan; 15(1):56-64. PubMed ID: 10634242
[TBL] [Abstract][Full Text] [Related]
8. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KD
Cochrane Database Syst Rev; 2001; 2001(1):CD001519. PubMed ID: 11279721
[TBL] [Abstract][Full Text] [Related]
10. Ropinirole for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; (1):CD001516. PubMed ID: 11279718
[TBL] [Abstract][Full Text] [Related]
11. Ropinirole for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2000; (3):CD001516. PubMed ID: 10908503
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke C E; Speller J M; Clarke J A
Cochrane Database Syst Rev; 2000; 2000(3):CD002259. PubMed ID: 10908539
[TBL] [Abstract][Full Text] [Related]
13. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
14. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Clarke C E; Speller J M
Cochrane Database Syst Rev; 2000; (2):CD000236. PubMed ID: 10796705
[TBL] [Abstract][Full Text] [Related]
15. Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Clarke CE; Speller JM
Cochrane Database Syst Rev; 2000; 1999(2):CD001514. PubMed ID: 10796800
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
Deane KH; Spieker S; Clarke CE
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD004553. PubMed ID: 15495118
[TBL] [Abstract][Full Text] [Related]
17. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
18. Cabergoline for levodopa-induced complications in Parkinson's disease.
Clarke CE; Deane KH
Cochrane Database Syst Rev; 2001; 2001(1):CD001518. PubMed ID: 11279720
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
Stowe R; Ives N; Clarke CE; Deane K; ; Wheatley K; Gray R; Handley K; Furmston A
Cochrane Database Syst Rev; 2010 Jul; (7):CD007166. PubMed ID: 20614454
[TBL] [Abstract][Full Text] [Related]
20. Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Weiner WJ; Factor SA; Sanchez-Ramos JR; Singer C; Sheldon C; Cornelius L; Ingenito A
Neurology; 1993 Jan; 43(1):21-7. PubMed ID: 8423888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
